GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human CBR1 in complex with hydroxy-pp

Analyse Crystal structure of human CBR1 in complex with hydroxy-pp in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1WMA
Type
protein
Length
275 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Carbonyl reductase [NADPH] 1
EC
1.1.1.184
UniProt
P16152
Ligands
AB3, NDP, SO4
Pockets
3 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 48% helix, 16% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACarbonyl reductase [NADPH] 1 (EC 1.1.1.184)protein27548% helix, 16% strandP16152

Ligands and binding sites

  • AB3 · 3-(4-amino-1-tert-butyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)phenol · ligand · 2 copies · chains A
  • NDP · Nadph dihydro-nicotinamide-adenine-dinucleotide phosphate · ligand · chains A
  • SO4 · Sulfate ion · ion · 7 copies · chains A
  • PE5 · 3,6,9,12,15,18,21,24-octaoxahexacosan-1-ol · additive · chains A
  • P33 · 3,6,9,12,15,18-hexaoxaicosane-1,20-diol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14490.700.8148SO4, AB3, NDP
2800.380.7712P33
3790.330.7515empty

Compared structures

  • 1WMA · Crystal structure of human CBR1 in complex with Hydroxy-PP · the same entry in another collection · chain A against A, TM-score 1.00
  • P16152 · AlphaFold monomer V2.0 prediction for carbonyl reductase [NADPH] 1 (P16152) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.